None listed
Conditions
Brief summary
The purpose for this fluid replacement is to maintain normal body homeostasis (balance). The theoretical advantages of a having normal acid-base balance is a lower incidence of postoperative complications i.e. less breathing difficulties, less heart and kidney complications, improvements in time to mobilise, and a shorter duration of hospital stay. During surgery fluid losses can occur from evaporative losses from your skin, losses from your urine, and losses from any bleeding that can result from the surgery. In Australia and most countries in the world, the most commonly used clear fluid to replace any fluid loss during liver transplantation is Plasmalyte solution. This is standard fluid therapy for all patients undergoing liver transplantation at Austin Health. Plasmlayte solution has certain limitations in that it contains certain electrolytes (also called “anions”) that are reliant on the liver for metabolism. During liver transplantation, as the liver does not function normally, this can affect normal “body-balance”. In this study we are investigating whether a clear fluid called “bicarbonate buffered solution” is comparable to Plamalyte solution during transplantation. This solution contains no “anions” and may have a more favourable effect on the “acid-base” balance.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Adult liver donor recipients aged 18 years or older Primary deceased donor liver transplantation including donation after brain death and donation after cardiac death Redo deceased donor liver transplantation
Exclusion criteria
Paediatric recipients aged 17 years of less Combined liver-kidney transplant Combined liver-small bowel transplant Fulminant hepatic failure End stage renal disease defined as a serum creatinine greater than 300 micromol per litre Pregnancy